Although indeterminate, there is some evidence that the clock may be dysregulated in pancreatic ductal adenocarcinoma (PDAC), leading to a worse prognosis [17,18]; this is alarming for a deadly malignancy where only 11% of patients survive beyond 5 years [19]. This evidence concerns the gene CLOCK and pancreatic ductal adenocarcinoma.